Civica Rx aims to supply drugs that are unavailable. Photo: George Frey/ Getty Images.

The nonprofit drug supplier Civica Rx, which aims to supply drugs that are unavailable due to shortage or price, will also try to force transparency about how money flows through the hands of middlemen.

What they're saying: "We will not pay listing fees or rebates to anybody in the middle of the process," CEO Martin VanTrieste said in a briefing on Thursday.

  • If a hospital wants to use, for example, its local wholesaler, Civica Rx will make it clear how much it's charging the wholesaler so that the hospital can know how much the wholesaler is keeping.
  • The hospital can then make a decision about whether they think the middlemen's services are worth the price tag.

Why it matters: This information isn't available for most drugs, and we don't know how much of a drug's price is absorbed by the supply chain. This model could help answer that question.

Go deeper: Trump administration proposes rolling back drug rebates.

Go deeper

The childless vaccine

Illustration: Eniola Odetunde/Axios

It'll likely be a long time before children are vaccinated against COVID-19, even though vaccinating kids could eventually play an integral role in reducing the virus' spread.

The big picture: None of the leading contenders in the U.S. are being tested for their effectiveness in children. Even once one of them gains authorization from the Food and Drug Administration, there will only be a limited number of available doses.

Progressives bide time for a Biden victory

Illustration: Sarah Grillo/Axios

Progressive Democrats want to beat President Trump so badly that they're tabling their apathy about Joe Biden — organizing hard to get him into office, only to fight him once elected.

Why it matters: That's a big difference from 2016, when progressives’ displeasure with Hillary Clinton depressed turnout and helped deliver the White House to Trump.

Election influence operations target journalists

Illustration: Aïda Amer/Axios

Foreign and domestic actors looking to influence the 2020 election are trying to trick real reporters into amplifying fake storylines. This tactic differs from 2016, when bad actors used fake accounts and bots to amplify disinformation to the population directly.

Why it matters: The new strategy, reminiscent of spy operations during the Cold War, is much harder for big tech platforms to police and prevent.